Bank of the Sierra reports record earnings
Sierra Bancorp reported record earnings boosted by lower loan and lease losses and improvements to the overall economy, the bank announced July 19. The parent company of Bank of the Sierra said it had $11.7 million in net income for the quarter ended June 30, or 76 cents per diluted share, compared to $8.3 million Read More →
Teledyne secures Navy contract worth up to $39M
Thousand Oaks-based Teledyne Technologies announced July 19 that its subsidiary, Teledyne Brown Engineering, was awarded a U.S. Navy contract for underwater drones worth as much as $39.2 million. The contract has a maximum base value of $27.4 million over five years, with five one-year option periods and a maximum value of $39.2 million if all Read More →
FDA accuses Amgen of misleading advertising
The U.S. Food and Drug Administration tagged Amgen with a letter July 7 that says the Thousand Oaks biotech firm made “misleading claims” in advertisements for its drug Neulasta, by suggesting it is more effective than biosimilar competitors. Neulasta is a prescription medication used to reduce infection risk from febrile neutropenia (a low level of Read More →
Region’s unemployment rate grew in June
Unemployment rates in the tri-county region crept back up in June, as the growth in jobs wasn’t enough to keep pace with an increase in people looking for work. The combined unemployment rate across Ventura, Santa Barbara and San Luis Obispo counties was 6.2% in June, up from 5.6% in May, according to data released Read More →
Tri-Counties will get 1,000 new vehicle charging stations
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Real Estate: Simi Valley industrial property sold for $20M
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
FDA gives Amgen priority review for asthma treatment
Thousand Oaks-based Amgen received a priority review for tezepelumab, a treatment for asthma, from the U.S. Food and Drug Administration, the biotech giant announced July 7. According to Amgen, tezepelumab is the first and only biologic to consistently and significantly reduce asthma exacerbations in a broad population of clients in phase 2 and 3 trials. Read More →
